Showing results (1-10 of 53) with videos related to
Sort By:
Pageof 6
Surgical Technology International|March 15, 2011
Extracorporeal therapies for refractory hypercholesterolemiaB R Gordon, S D SaalJournal of Clinical Apheresis|January 1, 1996
Low-density lipoprotein apheresis using the Liposorber dextran sulfate cellulose system for patients with hypercholesterolemia refractory to medical therapyB R Gordon, S D SaalCurrent Opinion in Lipidology|February 1, 1994
Advances in LDL-apheresis for the treatment of severe hypercholesterolemiaB R Gordon, S D SaalTherapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis|August 1, 1997
Clinical experience and future directions for low-density lipoprotein apheresis in the United StatesB R Gordon, S D SaalClinical and Experimental Dialysis and Apheresis|January 1, 1983
Post-partum hemolytic uremic syndrome: treatment with plasma exchangeB R Gordon, S D SaalCurrent Opinion in Lipidology|December 1, 1996
Current status of low density lipoprotein-apheresis for the therapy of severe hyperlipidemiaB R Gordon, S D SaalCancer|March 1, 1983
Plasmapheresis in a patient with angioimmunoblastic lymphadenopathy. Improvement in clinical and immunologic abnormalitiesB R Gordon, M Suthanthiran, S D Saal, et al.Proceedings of the National Academy of Sciences of the United States of America|February 1, 1986
Plasma high density lipoprotein is increased in man when low density lipoprotein (LDL) is lowered by LDL-pheresisT S Parker, B R Gordon, S D Saal, et al.Transfusion|May 1, 1990
Humoral immune response following extracorporeal immunoadsorption therapy of patients with hypercholesterolemiaB R Gordon, B J Sloan, T S Parker, et al.The American Journal of Medicine|November 1, 1989
Extracorporeal LDL cholesterol removal: role of LDL-pheresis in combination with other hypolipidemic therapy to regress vascular diseaseS D Saal, B R Gordon, T S Parker, et al.Pageof 6